enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
9.66
-0.34 (-3.40%)
At close: Mar 3, 2026, 4:00 PM EST
9.56
-0.10 (-1.04%)
After-hours: Mar 3, 2026, 4:25 PM EST
enGene Holdings Employees
As of October 31, 2025, enGene Holdings had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,430,512
Market Cap
647.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| ProKidney | 204 |
| Rigel Pharmaceuticals | 164 |
| Vor Biopharma | 154 |
| Alpha Tau Medical | 125 |
| Ocugen | 95 |
| Zura Bio | 30 |
ENGN News
- 11 days ago - enGene to Participate in Upcoming Investor Conferences - Business Wire
- 27 days ago - enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 5 weeks ago - enGene: Two Major Catalysts On Deck For 2nd Half Of 2026 - Seeking Alpha
- 6 weeks ago - enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - Business Wire
- 2 months ago - enGene Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire
- 3 months ago - enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness - Business Wire
- 3 months ago - enGene to Present at the Piper Sandler 37th Annual Healthcare Conference - Business Wire
- 3 months ago - enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants - Business Wire